Family Smoking Prevention and Tobacco Control Act Regulatory Research

The Family Smoking Prevention and Tobacco Control Act (TCA) provides the authority to regulate tobacco product manufacturing, distribution and marketing. Regulatory research will provide the scientific evidence to guide the implementation of this authority. Research areas include: 1) tobacco product composition and design 2), the toxicity of tobacco products, 3) addiction and abuse liability of tobacco products, 4) the short- and long-term health effects of tobacco products, 5) people�s behaviors related to tobacco product use and characteristics, 6) communicating to the public regarding nicotine and the health effects of tobacco products, 7) the influences of tobacco marketing on susceptibility and tobacco product use, and 8) the potential or actual impact of FDA regulatory actions. The strategic priorities for these research areas can be found at https://www.fda.gov/tobacco-products/research/research-priorities.

Applicants should review the eligibility information in the individual funding opportunity announcements issued under this CFDA.

Funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment. Relevance to Tobacco Control Regulatory Research program priorities will also be taken into consideration.